ROMANI, Luigina
 Distribuzione geografica
Continente #
NA - Nord America 11.962
EU - Europa 9.630
AS - Asia 3.529
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 16
OC - Oceania 7
Totale 25.198
Nazione #
US - Stati Uniti d'America 11.932
UA - Ucraina 2.645
IE - Irlanda 2.137
IT - Italia 1.260
SE - Svezia 1.074
SG - Singapore 1.065
HK - Hong Kong 1.025
DE - Germania 605
VN - Vietnam 600
FI - Finlandia 560
CN - Cina 515
RU - Federazione Russa 451
GB - Regno Unito 204
FR - Francia 141
TR - Turchia 137
AT - Austria 115
RO - Romania 90
CH - Svizzera 88
CZ - Repubblica Ceca 70
KR - Corea 66
BE - Belgio 56
NL - Olanda 41
PL - Polonia 41
UZ - Uzbekistan 39
CI - Costa d'Avorio 29
GR - Grecia 28
JP - Giappone 28
LB - Libano 26
CA - Canada 25
EU - Europa 19
BR - Brasile 9
IN - India 8
ID - Indonesia 6
BG - Bulgaria 5
CO - Colombia 4
MX - Messico 4
NZ - Nuova Zelanda 4
PH - Filippine 4
AU - Australia 3
HR - Croazia 3
SK - Slovacchia (Repubblica Slovacca) 3
BF - Burkina Faso 2
CL - Cile 2
IR - Iran 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
NG - Nigeria 1
PE - Perù 1
SC - Seychelles 1
SV - El Salvador 1
Totale 25.198
Città #
Chandler 2.299
Dublin 2.130
San Mateo 1.379
Jacksonville 1.362
Hong Kong 1.023
Boardman 827
Singapore 743
Dong Ket 599
Medford 574
Princeton 568
Perugia 454
Wilmington 430
Ann Arbor 418
Altamura 414
Andover 354
Lawrence 304
Des Moines 273
Beijing 199
Ashburn 175
Saint Petersburg 146
Falls Church 132
Izmir 130
Norwalk 115
Dearborn 106
Bucharest 71
Helsinki 69
Vienna 69
Los Angeles 60
Brno 56
Seoul 55
Brussels 54
San Paolo di Civitate 53
Woodbridge 50
Moscow 40
Redmond 38
Redwood City 31
Abidjan 29
Den Haag 28
Dallas 25
Shanghai 20
Guangzhou 19
Houston 19
Rome 18
Hefei 17
New York 17
Auburn Hills 16
Chicago 16
Munich 16
Fremont 15
Lausanne 15
Ottawa 15
San Diego 14
Santa Clara 14
Timisoara 14
Nanchang 11
Frankfurt Am Main 10
Milan 10
Nanning 10
Paris 10
Edinburgh 9
Kunming 9
Shenzhen 9
Tappahannock 9
Tokyo 9
Lappeenranta 8
Nanjing 8
Bologna 7
Chengdu 7
Hanover 7
Kocaeli 7
Macerata 7
Radomsko 7
Cambridge 6
Kiev 6
Olomouc 6
Philadelphia 6
Renton 6
Santarcangelo di Romagna 6
Torrile 6
Udine 6
Verona 6
Amsterdam 5
Camerino 5
Cardiff 5
Dorsten 5
Esslingen am Neckar 5
Florence 5
Fuzhou 5
Liphook 5
Monmouth Junction 5
Naples 5
Simi Valley 5
Collazzone 4
Como 4
Dervio 4
Hangzhou 4
Monreale 4
Pioltello 4
Turin 4
Atlanta 3
Totale 16.421
Nome #
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 123
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 121
Indole-3-aldehyde (IAld): a new potential drug for infectious and inflammatory diseases 116
Autophagy and LAP in the Fight against Fungal Infections: Regulation and Therapeutics 109
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 106
Antifungal Th Immunity: Growing up in Family 106
Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin 1. 97
Host Response Signatures to Invasive Aspergillosis 94
IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut 92
Cytokine- and T helper-dependent immunity in murine aspergillosis. 89
Adaptive immunity to Aspergillus 89
Increase of natural killer activity of mouse lymphocytes following in vitro and in vivo treatment with lithium. 89
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. 87
Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals. 86
T helper 2 antagonists restore antifungal T helper immunity in mice with T cell-depleted bone marrow transplantation 86
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis 86
Dectin-1 isoforms contribute to distinct Th1/Th17 cell activation in mucosal candidiasis. 85
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 83
Pathogenic NLRP3 Inflammasome Activity during Candida Infection Is Negatively Regulated by IL-22 via Activation of NLRC4 and IL-1Ra 82
Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. 81
Fine-tuning of Th17 Cytokines in Periodontal Disease by IL-10 81
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 81
Use of indole-3-aldehyde for treating dysreactive immune disorders 79
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 78
Immune regulation and tolerance to fungi in the lungs and skin. 77
Antigen-specific cytolysis of infected cells in murine candidiasis. 77
RATIONALE FOR CYTOKINE AND ANTI-CYTOKINE THERAPY OF CANDIDA-ALBICANS INFECTION 77
IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance 77
Cellular proteostasis: a new twist in the action of thymosin α1 77
Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. 75
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 75
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 74
NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. 73
Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. 73
Treatment of aspergillus infections with alpha thymosin peptides 71
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 71
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 71
Innate immunity against fungal pathogens. 70
The use of N-acetylcisteine as an immunomodulator in vivo and in vitro models of microbial infection 70
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 69
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 69
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 69
B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. 68
Sensing Danger Signals and Pathogen-Associated-Molecular Patterns defines binary signalling pathways in mammalian response to fungi Cellular and Cytokine Interactions in Health and Disease 68
Distinct and complementary roles for Aspergillus fumigatus-specific Tr1 and Foxp3+ regulatory T cells in humans and mice. 68
Biological role of Th cell subsets in candidiasis. 67
The interaction pattern of murine serum ficolin-a with microorganisms. 67
Activation of dendritic cells programs by fungi: implication for Th1/Th2 and regulatory responses. 67
Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils. 66
The long pentraxin PTX3 as a link between innate immunity, inflammation and female fertility. 66
A crucial role for tryptophan catabolism at the host/Candida albicans interface. 66
Antifungal type I responses are upregulated in IL-10-deficient mice. 66
Immunology of Aspergillus and Aspergillosis: The story so far 66
Antilymphoma graft responses in the mouse brain: a study of T-dependent functions. 66
Use of Thymosin alpha1 alone or in combination with PTX3 or ganciclovir for the treatment of cytomegalovirus infection 66
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1. 66
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis 66
Reply to ‘F508del-CFTR is not corrected by thymosin α1’ 66
Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. 65
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 65
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation 65
Antigenic changes related to drug action. 65
The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism 65
Learning from other diseases: protection and pathology in chronic fungal infections 65
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 65
Antifungal immune reactivity in nasal polyposis. 64
Advances in under standing of the pathogenesis of opportunistic fungal diseases: Aspergillosis 64
Microencapsulation of microbial derived indoles by spray drying 64
Immune sensing of aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. 63
An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. 63
A braking circuit between pathogen- and danger-sensing signaling pathways restrains lung inflammation: role of S100B protein, RAGE and Toll-like receptors. 63
Lectin-carbohydrate interactions during Aspergillus/DC cross-talk 63
Sensing of mammalian IL-17A regulates fungal adaptation and virulence. 63
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. 63
null 63
Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts 63
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 63
Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. 62
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. 62
IL-22 and IDO1 Affect Immunity and Tolerance to Murine and Human Vaginal Candidiasis 62
CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. 62
The circadian protein PER1 modulates the cellular response to anticancer treatments 62
Mechanisms of cell-mediated immunity in fungal infection. 61
Neutrophils and the adaptive immune response to Candida albicans. 61
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 61
Aspergillus and innate immunity: Infektiologischen/immunologischen Kolloquium 61
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. 61
A crucial role for tryptophan catabolism at the host/Candida albicans interface. 61
ANTI-CYTOKINE THERAPY OF MURINE CANDIDIASIS 61
Aspergillus fumigatus morphology and dynamic host interactions 61
The Potential Role of Toll-Like Receptor 4 in Mediating Dopaminergic Cell Loss and Alpha-Synuclein Expression in the Acute MPTP Mouse Model of Parkinson's Disease 61
Immunity to Aspergillus fumigatus: the bases for immunotherapy and vaccination. 60
Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. 60
Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans. 60
Immunoterapia delle infezioni fungine: principi e prospettive nel paziente sottoposto a trapianto 60
Host defense pathways against fungi: the basis for vaccines and immunotherapy. 60
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia. 60
Microbes in the Era of Circadian Medicine 60
Thymosin alpha1 mitigates intestinal immunopathology on immune checkpoint inhibition 60
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists. 59
Totale 7.218
Categoria #
all - tutte 113.279
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.279


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.940 0 0 0 0 402 107 507 49 490 179 45 161
2020/20214.753 23 437 110 418 1.476 182 392 26 506 125 406 652
2021/20224.729 94 930 115 220 219 88 74 1.545 85 105 516 738
2022/20237.662 609 1.142 98 614 705 933 18 384 2.787 23 252 97
2023/20243.027 202 364 143 57 42 27 632 82 460 108 402 508
2024/20251.357 85 745 131 354 42 0 0 0 0 0 0 0
Totale 26.337